Endava is expected to report Q4 2026 revenue of approximately $244.39 million and adjusted EPS of $0.15, with the stock currently trading at $1.65 compared to a $5.29 average analyst price target. Investors are primarily focused on the company's initial fiscal year 2027 guidance and a return to organic growth following a series of downward revisions.
Recent results were impacted by a substantial £364.6 million goodwill impairment and a significant loss of market value after missing Q3 expectations. While the company's AI-driven revenue has expanded to 15% of the total mix, persistent headwinds from delayed projects in the Middle East and extended deal cycles in the banking sector remain critical concerns for the upcoming report.